SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-148678
Filing Date
2020-05-21
Accepted
2020-05-21 16:12:41
Documents
17
Period of Report
2020-05-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d924592d8k.htm   iXBRL 8-K 37834
2 EX-1.1 d924592dex11.htm EX-1.1 180576
3 EX-5.1 d924592dex51.htm EX-5.1 7578
4 EX-99.1 d924592dex991.htm EX-99.1 7132
5 EX-99.2 d924592dex992.htm EX-99.2 7379
9 GRAPHIC g924592g65m33.jpg GRAPHIC 3536
  Complete submission text file 0001193125-20-148678.txt   428846

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA flxn-20200520.xsd EX-101.SCH 3045
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20200520_lab.xml EX-101.LAB 18138
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20200520_pre.xml EX-101.PRE 11391
15 EXTRACTED XBRL INSTANCE DOCUMENT d924592d8k_htm.xml XML 3403
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36287 | Film No.: 20901990
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences